The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126222631 12622263 1 I 20111020 20121024 20160804 20160804 EXP GB-PFIZER INC-1468993 PFIZER 51.00 YR F Y 62.00000 KG 20160804 MD GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126222631 12622263 1 PS VINCRISTINE SULFATE. VINCRISTINE SULFATE 1 Intravenous (not otherwise specified) 2 MG, EVERY 3 WEEKS 71484 2 MG SOLUTION FOR INJECTION Q3W
126222631 12622263 2 SS PREDNISONE. PREDNISONE 1 Oral 100 MG, EVERY 3 WEEKS 0 100 MG Q3W
126222631 12622263 3 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) 1280 MG, EVERY 3 WEEKS 0 1280 MG Q3W
126222631 12622263 4 SS RITUXIMAB RITUXIMAB 1 Intravenous (not otherwise specified) 500 ML, OF 1.35MG/ML CONC. B6044 0 500 ML Q3W
126222631 12622263 5 SS BENZYLPENICILLIN SODIUM PENICILLIN G SODIUM 1 UNK Y 0
126222631 12622263 6 C ALLOPURINOL. ALLOPURINOL 1 UNK 0
126222631 12622263 7 C BUSCOPAN BUTYLSCOPOLAMINE BROMIDE 1 UNK 0
126222631 12622263 8 C CHLORPHENIRAMINE. CHLORPHENIRAMINE 1 UNK 0
126222631 12622263 9 C DIPROBASE CHLOROCRESOL 1 UNK 0
126222631 12622263 10 C OMEPRAZOLE. OMEPRAZOLE 1 UNK 0
126222631 12622263 11 C ONDANSETRON ONDANSETRON 1 UNK 0
126222631 12622263 12 C PARACETAMOL ACETAMINOPHEN 1 UNK 0
126222631 12622263 13 C PARACETAMOL ACETAMINOPHEN 1 UNK 0
126222631 12622263 14 C SENNA SENNA LEAFSENNOSIDESSENNOSIDES A AND B 1 UNK 0
126222631 12622263 15 C SODIUM CHLORIDE. SODIUM CHLORIDE 1 UNK 0
126222631 12622263 16 C POTASSIUM BICARBONATE/POTASSIUM CHLORIDE 2 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126222631 12622263 1 Non-Hodgkin's lymphoma
126222631 12622263 2 Non-Hodgkin's lymphoma
126222631 12622263 3 Non-Hodgkin's lymphoma
126222631 12622263 4 Non-Hodgkin's lymphoma
126222631 12622263 6 Tumour lysis syndrome
126222631 12622263 7 Abdominal pain upper
126222631 12622263 9 Hypersensitivity
126222631 12622263 10 Dyspepsia
126222631 12622263 11 Tumour lysis syndrome
126222631 12622263 12 Pyrexia
126222631 12622263 14 Constipation
126222631 12622263 15 Tumour lysis syndrome

Outcome of event

Event ID CASEID OUTC COD
126222631 12622263 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126222631 12622263 Abdominal pain
126222631 12622263 Drug hypersensitivity
126222631 12622263 Febrile neutropenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126222631 12622263 1 20111011 0
126222631 12622263 2 20111011 0
126222631 12622263 3 20111011 0
126222631 12622263 4 20111011 0
126222631 12622263 5 20111027 20111028 0
126222631 12622263 6 20111010 20111215 0
126222631 12622263 8 20111010 0
126222631 12622263 9 20111026 20111101 0
126222631 12622263 10 20111010 0
126222631 12622263 11 20111011 20120308 0
126222631 12622263 12 20111011 0
126222631 12622263 13 20111101 0
126222631 12622263 14 20111010 20120308 0
126222631 12622263 15 20111010 20111010 0